Richard Englehardt, MD
Surgery · San Antonio, TXNPI 1225251002
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (49.9%), education and travel and lodging — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by Medical Device Business Services, Inc. at 54.0% of the total. Reporting peaked in 2024 at $69,529 and has fallen 68.0% since, to $22,271 in 2025. Among surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 349 payments — averaging $308.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$58K
- Intuitive Surgical$39K
- Johnson & Johnson$4K
- Baxter Healthcare$2K
- Medtronic$1K
- Novo Nordisk$723
- plus $2K from 29 others
Across 26 payments — averaging $4655.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ethicon Endo-surgery Inc.$82K
- Johnson & Johnson$39K
What the payments were for
- Consulting fees$53,69250%
- Speaking & faculty fees$1,9532%
- Travel & lodging$14,23313%
- Food & beverage$11,05210%
- Education$26,44625%
- Gifts$390%
- Entertainment$850%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 47 | $58,019 |
| Intuitive Surgical | 124 | $39,498 |
| Johnson & Johnson | 15 | $3,889 |
| Baxter Healthcare | 19 | $2,140 |
| Medtronic | 30 | $1,256 |
| Novo Nordisk | 45 | $723 |
| Lucid Diagnostics Inc. | 6 | $317 |
| W. L. Gore & Associates, Inc. | 3 | $304 |
| Lexington Medical, Inc. | 4 | $178 |
| Globus Medical | 1 | $133 |
| Lilly USA, LLC | 7 | $117 |
| Abbott | 4 | $84 |
| Davol Inc. | 3 | $79 |
| Nalpropion Pharmaceuticals LLC | 6 | $79 |
| Vivus LLC | 4 | $65 |
| Vertex | 2 | $64 |
| Currax Pharmaceuticals LLC | 4 | $63 |
| Rhythm Pharmaceuticals, Inc. | 3 | $62 |
| Reshape Lifesciences Inc. | 1 | $61 |
| Intra-sana Laboratories | 2 | $48 |
| Daiichi Sankyo Inc. | 2 | $38 |
| Redhill Biopharma Inc. | 2 | $38 |
| Endo Pharmaceuticals Inc. | 2 | $28 |
| Enterra Medical, Inc. | 1 | $27 |
| Fisher & Paykel Healthcare Inc | 1 | $26 |
| Mauna Kea Technologies, Inc. | 1 | $25 |
| Eisai Inc. | 2 | $23 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Medinc Of Texas | 1 | $18 |
| Eagle Pharmaceuticals, Inc. | 1 | $15 |
| LSI Solutions Inc | 1 | $15 |
| Covidien LP | 1 | $11 |
| Endogastric Solutions, Inc | 1 | $10 |
| Microline Surgical Inc | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$33,382
- LINX Reflux Management System$5,913
- DAVINCI XI$3,000
- TISSEEL$1,698
- PERI-STRIPS DRY$1,576
- FLOSEAL$1,453
- Signia$611
- SEAMGUARD$147
- GORE SEAMGUARD Bioabsorbable Staple Line Reinforce$134
- Senza$133
- EndoFlip$128
- ECHELON FLEX CST System$100
How this compares
$107,499 in reported general payments places this provider in the 95th percentile of 1,830 surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ursodiol | 30 | $3,753 |
| Dexlansoprazole DrDexlansoprazole | 12 | $3,221 |
| Sucralfate | 24 | $2,405 |
| Omeprazole | 76 | $1,064 |
| Sodium Chloride0.9 % Sodium Chloride | 39 | $871 |
| Ondansetron OdtOndansetron | 30 | $824 |
| Promethazine Hcl | 46 | $791 |
| Enoxaparin Sodium | 20 | $724 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 36 | $586 |
| Pantoprazole Sodium | 37 | $334 |
| Famotidine | 12 | $105 |
Paid to pharmacies, not to this prescriber.
Other surgery in San Antonio
- Richard PetersonSan Antonio$323K
- Joseph KaramSan Antonio$293K
- John PilcherSan Antonio$214K
- John MeterskySan Antonio$158K
- Kent van SickleSan Antonio$143K
- Guillermo Portillo RamilaSan Antonio$102K
- Michael HarkinsTomball$2.7M
- Douglas StoddardAustin$1.4M
- Steven FassAustin$989K
- Vineet ChoudhryAustin$851K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.